Objectives. Functional vertigo and dizziness (VD) are frequent and severely distressing complaints that are often described as hard to treat. Our aim was to provide preliminary data on potential effects of multimodal psychosomatic inpatient therapy for patients with functional VD symptoms in reducing vertigo-related handicap and related psychopathology, and to evaluate the role of symptom burden and body-related locus of control in predicting vertigo-related handicap at follow-up.
Practitioner points
The change of vertigo-related handicap and related variables through multimodal psychosomatic inpatient treatment was evaluated in a clinical pilot trial in patients with functional vertigo and dizziness. We observed medium effects for the change of vertigo-related handicap and small effects for the change of somatization, mental health-related quality of life, and depression. Internal body-related locus of control at admission did not predict vertigo-related handicap at followup.
Vertigo and dizziness (VD) are highly prevalent symptoms (Neuhauser, 2009) . VD symptoms can occur due to several organic pathologies, after an organic pathology has faded, or without an organic cause; that is, they can be of functional origin (Dieterich & Staab, 2017) . Regardless of their aetiology, VD symptoms are usually severely distressing and interfere with patients' every day and working life (Eckhardt-Henn, . It has been shown that they often occur comorbid with mental disorders, most prevalent diagnoses are somatoform, depressive, and anxiety disorders Lahmann et al., 2015) . In addition, the diagnosis of a somatic symptom disorder (SSD) which has been defined in DSM-5 is highly prevalent and persistent (Limburg, Sattel, Radziej, & Lahmann, 2016; Limburg et al., 2017) .
A systematic review provided some preliminary evidence that outpatient cognitivebehavioural psychotherapy (CBT) may be effective in reducing vertigo-related handicap; however, the review was unable to determine the long-term efficacy of these interventions since follow-up evaluations were and still are rare (Schmid, Henningsen, Dieterich, Sattel, & Lahmann, 2011) . CBT has also been proven effective in specific somatoform disorders and functional complaints such as irritable bowel syndrome, fibromyalgia, or chronic fatigue syndrome (Henningsen, Zipfel, Sattel, & Creed, 2018) . In addition, there is some evidence that psychodynamic interpersonal therapy can reduce somatization and improve physical quality of life (Sattel et al., 2012) . To investigate the efficacy of the intervention in patients with VD symptoms, a similar treatment programme that has been tailored to these patients and common comorbid psychopathologies is currently being evaluated (Radziej, Schmid-M€ uhlbauer, Limburg, & Lahmann, 2017) .
Although outpatient treatment has been shown to be effective, under certain circumstances inpatient treatment may be preferred. Factors such as insufficient improvement in outpatient psychotherapy, severe somatic or psychological comorbidity, severely limited psychosocial functioning (e.g., long-lasting inability to work or major conflicts at home), and/or severe biographical stressors can be indicators to refer patients with functional symptoms such as VD to psychosomatic inpatient treatment (Lahmann, Henningsen, Noll-Hussong, & Dinkel, 2010; Schaefert et al., 2012) . Of note, this form of treatment currently is specific to the German health care system, findings regarding its effectiveness may however be of general relevance. Psychosomatic inpatient therapy applies a biopsychosocial approach to treating illness and as such goes beyond what is known as 'medical rehabilitation' in other countries. It has been described in more detail by Linden (2014) . Regarding multimodal psychosomatic inpatient therapy, findings of a study in patients with long-lasting VD symptoms suggest effectiveness of an integrated approach including psychotherapy as well as vestibular and balance training (Schaaf & Hesse, 2015) ; the latter has been shown to be a useful intervention for interoceptive exposure training to feared sensations, that is, VD symptoms (Staab, 2011) . Otherwise, evaluations of multimodal psychosomatic inpatient treatment for patients with persistent VD symptoms are rare, although this form of treatment is recommended by the current German clinical practice guideline for patients with severely impairing and chronic functional symptoms (Schaefert et al., 2012) .
Next to evaluating treatment effectiveness, it is of interest to identify factors which contribute to improvement or rather, which factors may hinder improvement. In psychosomatic inpatient treatment of somatoform disorders, psychological symptoms such as intolerance of bodily complaints, health habits, and somatic attribution have been shown to be predictive of physical functioning at 12-month follow-up (Voigt et al., 2013) .
Regarding the development and/or maintenance of somatoform disorders or functional complaints, established predictors are female gender (Lieb et al., 2002; Speckens, Van Hemert, Bolk, Rooijmans, & Hengeveld, 1996) , high physical symptom count (olde Hartman et al., 2009; Tomenson et al., 2013) , self-reported psychological distress (Jørgensen, Fink, & Olesen, 2000) , alexithymia, that is, a deficit in perceiving and expressing emotional states, and/or impaired affect regulation (e.g., Duddu, Isaac, & Chaturvedi, 2003; Probst, Sattel, Henningsen, Gundel, & Lahmann, 2017; Waller & Scheidt, 2004) . Further, internal body-related locus of control has been found to be related with bodily well-being (Albani et al., 2007) , whereas external (or uncontrollable) illness attributions such as vulnerability or organic causes have been associated with somatoform disorders, more illness behaviour, and thus a higher somatic symptom burden (Rief, Nanke, Emmerich, Bender, & Zech, 2004) . Despite its association with somatoform disorders, to our current knowledge, body-related locus of control has not been investigated regarding its role in predicting somatoform disorders and/or treatment outcome yet. Since a high somatic symptom burden is an established predictor of somatoform disorders, it would be worthwhile to evaluate the predictive role of both somatic symptom burden and body-related locus of control to identify whether an internal locus of control would still be beneficial despite a high symptom burden.
Aims and hypotheses
The present study aimed to provide preliminary data on potential effects of a multimodal psychosomatic inpatient treatment programme for patients suffering from functional VD symptoms and comorbid psychiatric and somatic pathologies in reducing vertigo-related handicap as the primary outcome, vertigo symptom severity, comorbid psychopathology, and enhancing health-related quality of life (HRQOL). The second aim was to evaluate whether somatic and psychopathologic symptom burden and body-related locus of control are predictors of improvement of vertigo-related handicap.
Methods

Participants
All patients with functional VD as a main complaint who were admitted for inpatient treatment at the Department for Psychosomatic Medicine and Psychotherapy of the Technical University of Munich, Germany, between 2012 and 2016 were eligible. Prior to admission, patients were examined by a psychosomatic specialist and a clinical interview was carried out. Psychiatric diagnoses were assessed after the classification system ICD-10 (World Health Organization, 2013) . Physical diagnostics were assessed by specialized physicians. It was evaluated whether all medical examinations necessary to decide whether the complaints were of a functional origin had been carried out. If examinations were incomplete, patients were transferred to appropriate specialists prior to admission, for example to the German Centre for Vertigo and Balance Disorders. Patients were referred to our department from primary care, secondary care (e.g., neurologist), or tertiary care (i.e., the German Centre for Vertigo and Balance Disorders). Contraindications were severe psychiatric conditions (i.e., psychosis, addiction disorders, severe or acute suicidal tendencies) or severe cognitive impairments such as dementia, and insufficient German language abilities. All patients were seen in the outpatient department first. Those patients with an indication for inpatient treatment were contacted via telephone during the waiting period prior to admission and informed about the study. Thereafter, informed consent was obtained. During the course of the study, patients were asked to complete a set of self-report questionnaires at admission (T0), discharge (T1), and 6-month follow-up (T2). Single missing data at follow-up were estimated using a multiple imputation approach, as described below. The study was approved by the ethical committee of the medical faculty of the Technical University of Munich. The principles of the Declaration of Helsinki and the GCP Guidelines were followed.
Psychosomatic inpatient treatment
Psychosomatic inpatient treatment usually is multimodal and multidisciplinary, with a clear focus on psychotherapeutic interventions and not comparable to inpatient psychiatric treatment. The type of psychotherapeutic treatment applied varies considerably between the different hospitals in Germany. Hospitals offer psychodynamic, cognitive-behavioural, or specialized concepts, or they may combine several approaches in an integrative way. In case of a psychodynamic treatment model, psychodynamic principles of structural psychopathology are often applied (Cierpka, Grande, Rudolf, von der Tann, & Stasch, 2007; Westen, Gabbard, & Blagov, 2006) ; that is, patients are treated according to their level of personality structure while aiming at reducing their psychopathological symptomatology.
In our study, patients were treated according to a psychodynamic approach, taking levels of personality structure into account. The average duration of treatment in our department is 40 days, and the patients included in the current study were treated on average for 43.2 (SD = 16.0) days. In addition to medical-somatic treatment, patients received psychotherapeutic one-on-one sessions (2 9 50 min per week), group psychotherapy (2 9 75 min per week), and patient-centred nursing as standard therapeutic elements. Aside from that, there are further interventions that are tailored to each patient in terms of therapeutic focus, dosage and frequency. These interventions include bodypsychotherapeutic treatment, counselling from a social worker, art therapy, patient education, and physiotherapeutic interventions. It is important to note that interventions do not only focus on the vertigo complaints, but take into account the broader context in which a patient's symptoms appear. This is in line with current clinical practice guidelines that recommend multimodal treatment for patients with severe functional symptoms (Schaefert et al., 2012) . The treatment is based on a biopsychosocial perspective. Therefore, treatment aims at targeting the complaints from all three perspectives, that is by establishing medical diagnostics and taking necessary steps, changing feelings, behaviours, and thoughts regarding the complaints as well as considering and -if necessary -amending a patient's social circumstances. Since the treatment is not manualized, contents can vary depending on each patient's specific pathology, comorbidities, and circumstances. All in all, treatment of patients with functional VD therefore differed only slightly from psychosomatic inpatient treatment for patients with different disorders. For example, patients with VD received more vertigo-specific physiotherapy. Hence, specific needs of patients with functional VD were able to be addressed and the programme can be considered feasible in the context of psychosomatic inpatient treatment. To maintain treatment fidelity, there were regular team meetings, clinical supervision sessions, and ward rounds. In terms of acceptability, patients' treatment satisfaction and subjective treatment success have been rated high (Hertle, 2016) .
Assessment
Self-report questionnaires
Patients completed a set of self-report questionnaires at baseline, discharge, and 6-month follow-up either at home or in the hospital. The following instruments were applied: The Vertigo Handicap Questionnaire (VHQ; Tschan et al., 2010; Yardley, Masson, Verschuur, Haacke, & Luxon, 1992; Yardley & Putman, 1992 ) was used to measure physical and psychosocial handicap caused by VD which was defined as the primary outcome. It consists of 45 items rated on 5-point Likert scales and allows to calculate a sum score over all items to get an index of vertigo-related handicap. Higher scores indicate larger handicap. The German version of the VHQ has been proven to be internally consistent (Cronbach's a: .92; Tschan et al., 2010) . In our sample, we observed a = .93.
The following measures were applied to assess secondary outcomes: We used the Vertigo Symptom Scale (VSS; Tschan et al., 2008; to capture the subjective vertigo severity and related anxiety. It consists of 34 items rated on 5-point Likert scales that are used to establish two subscale sum scores representing a Vertigo (VER) Scale and an Autonomic Arousal (AA) Scale, the latter representing vertigo-related anxiety expressed by autonomic arousal. Higher scores on the scales indicate higher impairment regarding the two aspects. Both scales of the German version of the VSS are internally consistent (Cronbach's a: VER: .79, AA: .89; Tschan et al., 2008) ; in our sample, we observed a = .89 for VER and a = .90 for AA.
The sum score of the Patient Health Questionnaire-15 (PHQ-15; Gr€ afe, Zipfel, Herzog, & L€ owe, 2004; Kroenke, Spitzer, & Williams, 2002) was applied to establish an index of somatization. It consists of 15 items in total: 13 of those assess bodily symptoms regarding their severity and two items assess depressive symptoms regarding their prevalence on a 3-point scale. The German version has been shown to have an internal consistency of a = .79-.88 (Gr€ afe et al., 2004) ; in our sample, we found a = .83.
We administered the Short Form Health Survey (SF-36; Bellach, Ellert, & Radoschewski, 2000; Ware, Kosinski, & Keller, 1996) to assess physical and mental HRQOL. The SF-36 consists of eight subscales representing physical functioning, physical role functioning (capturing role limitations due to physical health problems), bodily pain, general health perceptions, vitality, social functioning, emotional role functioning (capturing role limitations due to emotional health problems), and mental health. The z-scores of the subscale scores are then multiplied with a regression coefficient for a physical or mental factor, respectively, and added. Internal consistency has been estimated at a = .94 for the physical factor and a = .89 for the mental factor (Gandek, Sinclair, Kosinski, & Ware, 2004) ; in our sample, we observed a = .87 and a = .88 for the respective factors.
The sum scores of the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996; Hautzinger, Keller, & K€ uhner, 2006 ) and the Beck Anxiety Inventory (BAI; Beck & Steer, 1990; Margraf, Beck, & Ehlers, 2007) were used to measure the severity of depression and anxiety, respectively. Both BDI-II and BAI consist of 21 items that can be rated from 0 to 3. For the BDI-II, sum scores of 14-19 indicate mild depression, 20-28 indicate moderate depression, and scores of 29-63 indicate severe depression. For the BAI, sum scores of 10-16 indicate mild anxiety, 17-29 indicate moderate anxiety, and 30-63 indicate severe anxiety. In terms of internal consistency, we found a = .92 and a = .93 for BDI and BAI, respectively, in our sample.
All previously mentioned scales have been used in intervention studies before. For example, VHQ, VSS, and PHQ have been applied by Tschan et al. (2012) , the SF-36 has been used by Sattel et al. (2012) , the BDI-II has been implemented by Kleinst€ auber, Lambert, and Hiller (2017) , and the BAI was used in studies included in a meta-analysis by Cuijpers et al. (2016) to assess differences on the corresponding outcomes before and after therapy. Thus, sufficient sensitivity to change can be assumed for the measures we applied to assess treatment effects.
The Body-Related Locus of Control questionnaire (KLC; Albani et al., 2007; Mrazek, 1989) with its two subscales covering internal and external body-related locus of control was applied to assess the two corresponding dimensions. Body-related locus of control refers to the concept of whether a person perceives that he or she has control over bodily symptoms (internal locus of control) or interprets the symptoms as by chance or due to outer influences that cannot be controlled by the person him-/herself (external locus of control). The KLC has been developed in German and consists of 18 items rated on 5-point Likert scales, and the two subscales are built by adding the scores of their nine corresponding items. The scales have been tested in two large norm samples (Albani et al., 2007; Mrazek, 1989 ) and shown to be internally consistent (Cronbach's a = .83 for external locus of control, .82 for internal locus of control; Albani et al., 2007) . In our sample, we found a = .84 for external and a = .85 for internal Locus of Control.
Statistical analysis
Statistical analyses were conducted using SPSS 23.0 (IBM Corp., Armonk, NY, USA) statistical package. Prior to analysis, data screening revealed between 15% and 20% missing data on single relevant variables within the study sample of n = 72 patients. Thus, multiple imputation was applied to get an estimate of single missing data in concerned patients (L€ udtke, Robitzsch, Trautwein, & K€ oller, 2007) by using the multiple imputation algorithm in SPSS 23.0. The algorithm imputes five datasets; all following analyses are conducted on each of these datasets. The results of these analyses are then pooled and as such depicted below.
We utilized descriptive statistics to evaluate sample characteristics including psychiatric and somatic diagnoses. We applied multivariate analyses of variance (MANOVA) with repeated measurements to assess treatment effects across baseline, discharge and follow-up. We used Hedges' g as an effect size measure for the differences between time points. Effect sizes were interpreted as follows: small effect if 0.2 ≤ | g| < 0.5, medium effect if 0.5 ≤ |g| < 0.8, large effect if |g| > 0.8 (Cohen, 1988) . In addition, according to Angst, Aeschlimann, and Angst (2017) , an effect size between 0.30 and 0.50 was considered as being minimally clinically important. The minimal clinically important difference (MCID) is a parameter that assists in deciding whether a difference in symptom intensity is subjectively perceivable for a patient and thus clinically meaningful (Angst et al., 2017) . Hierarchical linear regression analyses were conducted to analyse regression models predicting the primary outcome, vertigo-related handicap, at 6-month follow-up. We tested three models altogether, each model including the control variables age, gender, and vertigo-related handicap at baseline. In addition to the control variables, Model 2 also contained the numbers of psychiatric and somatic diagnoses as indicators of psychopathological and somatic symptom burden. In Model 3, we added internal locus of control and external locus of control as predictors.
Results
A total of 98 patients gave their informed consent prior to admission to inpatient treatment. Due to admission cancellations and incomplete return of questionnaires, we obtained 72 complete datasets at admission (T0), discharge (T1), and 6-month follow-up (T2). A diagram of the patient flow and reasons for dropout is depicted in Figure 1 . Sociodemographic and medical characteristics of the sample (n = 72) along with a sensitivity analysis comparing study sample and dropout group are presented in Table 1 . Study sample and dropout group differed significantly regarding education with the dropout group being more highly educated. Otherwise, there were no significant differences. Patients of the study sample presented with an average of 2.4 (SD = 0.8, range: 1-4) psychiatric and 2.5 (SD = 1.8, range: 0-4) somatic diagnoses, the most prevalent primary psychopathological conditions were somatoform disorders (88.9%), and the most prevalent somatic diagnoses were diseases of the inner ear and vestibular organ (20.5%). Table 2 . On average, patients presented with clinically relevant impairment on all psychopathology and handicap measures at baseline. The primary outcome vertigorelated handicap significantly decreased during the study period, and effect sizes (Hedges' g) were medium, M (SD) T0 = 54.03 (18.05), M (SD) T1 = 43.23 (20.89), M (SD) T2 = 41.89 (20.66), Hedges' g T0-T1 = À0.60***, g T0-T2 = À0.67***). Thus, the change of vertigorelated handicap can be considered as being clinically important. The secondary outcomes somatization and the severity of depression symptoms also significantly decreased while mental quality of life significantly increased during the study period. Effect sizes were small for the change of somatization, mental HRQOL, and depression from admission to discharge and admission to follow-up. Effect sizes were above 0.3 and thus minimally clinically important for the increase in mental HRQOL and the decrease in depression. Changes in vertigo severity, physical quality of life, and anxiety were not significant.
Effectiveness of intervention A comparison of handicap and psychopathology measures across the time points is depicted in
Prediction of vertigo-related handicap at follow-up
Hierarchical linear regression analyses showed that vertigo-related handicap at admission was the only significant predictor of vertigo-related handicap at follow-up in all models. All other investigated predictors did not have significant predictive value. The final Model 3 explained approximately the same amount of variance as Model 1, indicating that additional predictors (number of psychiatric and somatic diagnoses, internal and external body-related locus of control) did not add predictive value beyond the control variables included in Model 1 (see Table 3 ). The same analyses were conducted for vertigo-related handicap at discharge as a dependent variable. Results were similar; that is, vertigo-related handicap at admission was the only significant predictor.
Discussion
Findings and implications
In the present pilot trial, we investigated potential effects of a multimodal psychosomatic inpatient treatment programme for patients with functional VD symptoms reporting high somatic and psychopathological symptom burden in reducing vertigo-related handicap, vertigo severity, and related psychopathology and improving HRQOL during the time of Step <.001
Step psychosomatic admission and at 6-month follow-up. We observed medium and clinically important effects regarding vertigo-related handicap, while effects in improving somatization, mental quality of life, and depression were small and only partly clinically important. Improvements remained stable beyond the time of inpatient treatment until 6-month follow-up. Levels of depression remained constant during follow-up. To our knowledge, no previous study evaluating psychosomatic inpatient treatment for patients with functional VD symptoms exists. In comparison with outpatient psychotherapeutic treatment, our effects in reducing vertigo-related handicap, depression, and anxiety both from admission to discharge and follow-up are larger than those observed in a systematic review by Schmid et al. (2011) who found medium effects (Cohen's d = 0.46) for vertigorelated handicap and no significant effects for depression and for anxiety. Effects are also larger than those observed by Tschan et al. (2012) who examined outpatient CBT with a 12-month follow-up and observed very small effect sizes for reducing handicap and nonsignificant effects for anxiety, depression, and somatization. Similar to our findings, Tschan et al. as well observed a very small reduction in vertigo symptom severity measured with the VSS. Compared to effects observed in previous evaluations of psychosomatic inpatient treatment programmes for patients with various disorders (Wunner, Reichhart, Strauss, & Sollner, 2014) and somatoform pain (Pieh et al., 2014) who found medium to large effects for depression, our observed effects in reducing depression are smaller. Regarding somatization, our effects are similar to those found by Wunner et al. (2014) . Effects for depression and anxiety were also smaller compared to a study evaluating an inpatient treatment programme for patients with VD symptoms of various underlying structural, that is organic, causes (Schaaf & Hesse, 2015) . In addition, our effects were slightly smaller compared to a meta-analysis of psychotherapeutic inpatient treatment that found overall medium effects in reducing handicap parameters (Liebherz & Rabung, 2013) . The fact that our study brought up smaller improvements than previous studies in patients with different psychosomatic disorders may indicate that patients with functional VD symptoms as a main complaint represent a severely impaired patient group. This is also shown by the high number of comorbidities and high baseline psychopathology scores. Further, our patients had very small and nonsignificant reductions of vertigo symptom severity. This aspect is in accordance with studies describing VD as a chronic condition that is hard to treat (Dieterich & Staab, 2017) .
Regarding our second aim, investigating body-related locus of control along with somatic and psychiatric symptom burden as predictors of improvement of vertigorelated handicap, our regression analyses demonstrated that none of the investigated variables had predictive value beyond the control variables. This was unexpected since internal locus of control has been discussed as advantageous in various contexts (Fresson, Dardenne, Geurten, & Meulemans, 2017; Goldzweig, Hasson-Ohayon, Alon, & Shalit, 2016; Rizza et al., 2017) . Further, patients with somatoform disorders and functional symptoms have been found to present with more maladaptive illness perceptions compared to patients with physical symptoms and no somatoform disorder; low personal control has been linked to higher health care use in patients with somatoform disorders (Frostholm, Petrie, Ørnbøl, & Fink, 2014) . Baseline psychopathological and somatic symptom burden, that is the number of comorbidities, also did not prove to be influencing improvement. Hence, psychosomatic inpatient treatment can be beneficial even for severely suffering patients with a high symptom burden. One has to keep in mind, though, that effects are in the medium or small to medium range; thus, our provided treatment may be a first important step in initiating improvement; to maintain the effects, additional outpatient psychotherapy probably is needed. To further investigate predictors of improvement in psychosomatic inpatient treatment of patients with VD, it would be worthwhile to evaluate the role of other established predictors. For example, previous authors found health anxiety and healthrelated cognitions to be predictive of physical functioning of psychosomatic inpatients at follow-up (Voigt et al., 2013) ; those factors may be relevant in patients with functional VD, too.
Strengths and limitations
To our knowledge, this is one of the first studies investigating multimodal psychosomatic inpatient therapy for patients with severely impairing and persistent functional VD symptoms. Our sample includes patients with various comorbid conditions. Due to this naturalistic setting, the external validity of our findings is high. We investigated the change in a range of outcome variables and observed consistent and lasting improvement; however, effect sizes were mostly medium or small. Limitations include the fact that we did not apply a randomized controlled study setting. Therefore, we are unable to draw causal conclusions due to our study design. Although a waitlist control group would have been an option, considering the high baseline psychopathology levels of our patients, it seemed problematic to implement a control group that does not receive treatment at all. Despite this major limitation, we believe that the results of this pilot trial still contribute meaningful evidence. As stated above, VD symptoms often take a chronic course (Dieterich & Staab, 2017; Limburg et al., 2017) and as such, it is not to be expected that they improve due to their natural course in a relatively short period of time of 40 days. Consequently, it can likely be assumed that the treatment did have effects on the symptom reduction that was observed in our analysis. Nevertheless, to be able to draw more substantial or causal conclusions on whether the treatment led to symptom change, future controlled studies are necessary. Hence, the current study can be considered a pilot trial that requires further investigations to verify our findings. Furthermore, although a variety of administered therapeutic interventions (e.g., group and one-on-one psychotherapy) are part of the standard therapy programme, the multimodal treatment approach of our clinic includes that the therapeutic programme is individually compiled towards the needs of each patient. In addition, long-term psychosomatic inpatient treatment is still rather specific to the national German health care system. This aspect limits the generalizability of our findings. Another limitation is that all our outcome measures were self-report questionnaires and may hence limit the interpretability of our findings.
Conclusion
Our findings point out that a multimodal psychosomatic inpatient treatment for patients with functional VD symptoms may be beneficial in reducing vertigo-related handicap and related aspects of psychopathology. The expected role of internal bodyrelated locus of control in predicting improvement could not be confirmed. Other variables such as health anxiety or health-related cognitions may be more relevant predictors.
